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Background: Pharmacological stimulation of peroxisome proliferator-activated receptor-gamma (PPAR-γ) has been
recognized as a molecular switch in alleviating myocardial injury through modulating oxidative, inflammatory and
apoptotic signaling pathways. This study was designed to elucidate the effect of chrysin, a novel PPAR-γ agonist
and its functional interaction with TGF-β/MAPKs in isoproterenol-challenged myocardial injury in rats.
Methods: Male Wistar Albino rats were either subjected to vehicle (1.5 mL/kg, p.o.) or chrysin (15–60 mg/kg, p.o.)
for 28 days. Isoproterenol (85 mg/kg, s.c.) was administered to rats on 27th and 28th day to induce myocardial
injury.
Results: Chrysin dose dependently improved ventricular (±LVdP/dtmax and LVEDP) and hemodynamic (SAP, MAP
and DAP) dysfunction in isoproterenol-insulted rats. This beneficial effect of chrysin was well supported with increased
expression of PPAR-γ and decreased expression of TGF-β as evidenced by western blotting and immunohistochemistry
analysis. Moreover, downstream signaling pathway of TGF-β viz. P-ERK½/ERK½ activation and P-JNK/JNK, P-p38/p38
and MMP-2 inhibition were also observed. Chrysin also attenuated NF-κBp65 and IKK-β expressions, TNF-α level and
TUNEL positivity thereby validating its anti-inflammatory and anti-apoptotic properties. Additionally, chrysin in a dose
dependent fashion improved NO level, redox status of the myocardium (GSH and MDA levels and SOD, GSHPx and
CAT activities), cardiac injury markers (CK-MB and LDH levels) and oxidative DNA damage marker (8-OHdG level) and
displayed preservation of subcellular and ultrastructural components.
Conclusion: We established that activation of PPAR-γ and inhibition of TGF-β via MAPKs dependent mechanism is
critical for cardioprotective effect of chrysin.
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Peroxisome proliferator-activated receptor-gamma (PPAR-γ)
is a transcription factor which apart from regulating glu-
cose and lipid metabolism also controls cardiac metabolic
hemostasis. Functionally, PPAR-γ stimulation plays a
crucial role in controlling the expression of various
genes involved in myocardial inflammatory and apop-
totic signaling pathways. Moreover, cardiac PPAR-γ* Correspondence: dsarya16@hotmail.com
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unless otherwise stated.constitutively regulates redox hemostasis and is crucial
in protecting cardiomyocytes from oxidative damage
[1-3]. Additionally, PPAR-γ agonism was shown to in-
crease cell survival in various models of myocardial in-
jury [4]. Likewise, growing scientific evidence suggests
that cross-talk between PPAR-γ and transforming
growth factor-beta (TGF-β) regulates cardiomyocyte
proliferation and differentiation [5-8]. Downstream
pathways of TGF-β signaling including p38 mitogen-
activated protein kinase (p38), extracellular signal-
regulated kinase (ERK½), c-Jun N-terminal kinases
(JNK) and matrix metalloproteinase-2 (MMP-2) wasis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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jury, repair and remodeling and their pharmacological
modulation have yielded significant outcomes in pre-
clinical and clinical settings of various cardiovascular dis-
eases including dilated cardiomyopathy, hypertrophy and
myocardial infarction [8,9].
Interestingly, activation of PPAR-γ and simultaneously
inhibition of TGF-β by various synthetic and phyto-
pharmaceutical molecules was shown to abrogate the
myocardial injury in rats. For instance, telmisartan and
L-carnitine has been found to protect against arterial
hypertension-related cardiac fibrosis and improve left
ventricular remodeling in rats via activating PPAR-γ
and inhibiting TGF-β signaling pathway [5,10]. Simi-
larly, osthole, a phytopharmaceutical, has been re-
ported to reduce isoprenaline-induced myocardial
injury in mice via activating PPAR-γ and simultan-
eously inhibiting TGF-β expression [11]. In the same
line of assumption we anticipated that chrysin (5,7-
Dihydroxyflavone) a natural flavonoid obtained from
honey (a highly nutritious food), propolis, and many
fruits and vegetables could be of therapeutic interest as
it possess PPAR-γ agonist activity [12]. Furthermore,
the effect of chrysin on myocardial injury is still elusive. Ac-
cordingly, this study was designed to determine whether
treatment with chrysin could improve the hemodynamic
and ventricular dysfunction in isoproterenol-induced ani-
mal model of myocardial injury. Secondly, if so, could the
activation of PPAR-γ and inhibition of TGF-β be the
plausible mechanism in ameliorating isoproterenol-
induced myocardial injury via modulating oxidative,
apoptotic and inflammatory signaling pathways. Thus,
for the first time we propose to evaluate the cardiopro-
tective effects of chrysin based upon its effects on
hemodynamic, biochemical, immunohistochemical, mo-
lecular, histopathological and electron microscopy.
Materials and methods
Animals
Male Wistar Albino Rats (4–6 weeks old, weighing
150–200 g) were approved and procured from Institu-
tional Animal Ethics Committee of All India Institute of
Medical Sciences, New Delhi, India (IAEC No. 716/13).
All experiments were performed in accordance with the
Indian National Science Academy Guidelines for the
use and care of experimental animals. The rats were
allowed free excess to standard pellet diet and tap water
ad libitum and kept in polypropylene cages under relative
humidity (60 ± 5%) and controlled temperature (25 ± 2°C)
and subjected to light–dark cycle of 12:12 h.
Reagents
Chrysin and isoproterenol was procured from Sigma
Chemical Company (St. Louis, MO, USA) and wassuspended in 0.5% carboxymethyl cellulose and dissolved
in normal saline respectively. p44/42 MAPK (ERK½)
(137 F5), phospho-p44/42 MAPK (ERK½) (Thr202/
Tyr204), SAPK/JNK, phospho-SAPK/JNK (Thr183/
Tyr185), TGF-β and IKK-β (L570) antibodies were pur-
chased from Cell Signaling Technology, USA. PPAR-γ
and P-p38 antibodies were purchased from Santa Cruz,
USA and MMP-2, p38, β-actin, and NF-κBp65 anti-
bodies were procured from Abcam Technologies, USA.
Secondary antibodies were purchased from Merck
GeNei, India. Creatine Kinase isoenzyme-MB (CK-MB)
(Spinreact, Spain), 8-hydroxy-2′-deoxyguanosine (8-OHdG)
(BMassay, Beijing, China), Rat Tumor necrosis factor-alpha
(TNF-α) (Diaclone Tepnel Company, UK) and Lactate De-
hydrogenase (LDH) isoenzyme (Logotech, Delhi, India) kits
were used.
Experimental protocol
Rats were divided into six groups with 10 animals in
each group viz.
Group 1 (Sham): Rats were administered 0.5% carbox-
ymethyl cellulose orally (1.5 mL/kg) for a period of
28 days. Consecutively, on 27th and 28th day the experi-
mental animals were subcutaneously injected normal
saline (1.5 mL/kg).
Group 2 (ISO): Rats were administered 0.5% carboxy-
methyl cellulose orally (1.5 mL/kg) for a period of
28 days. Consecutively, on 27th and 28th day the experi-
mental animals were subcutaneously injected iso-
proterenol (85 mg/kg) to induce myocardial injury.
Groups 3–5 (Chr15, 30, 60 + ISO): Rats were adminis-
tered chrysin (15, 30 and 60 mg/kg, p.o., respectively)
for a period of 28 days. Consecutively, on 27th and 28th
day the experimental animals were subcutaneously
injected isoproterenol (85 mg/kg).
Group 6 (Chr60ps): Rats were administered chrysin
(60 mg/kg, p.o., respectively) for a period of 28 days.
Consecutively, on 27th and 28th day the experimental
animals were subcutaneously injected normal saline
(1.5 mL/kg).
Induction of myocardial injury
Myocardial injury was carried out by injecting iso-
proterenol consecutively on 27th and 28th day of the
protocol. On the 29th day, rats were anesthetized with
pentobarbitone sodium (60 mg/kg, i.p.) and a midline in-
cision was given to open the chest. After 15 min of
stabilization period, hemodynamic and left ventricular
functions such as systolic arterial pressure (SAP), dia-
stolic arterial pressure (DAP), mean arterial pressure
(MAP), heart rate (HR), maximum speed of pressure de-
velopment (±LVdP/dtmax) and the left ventricular end-
diastolic pressure (LVEDP) were recorded using Biopac
system software BSL 4.0 MP36. After completing the
Rani et al. Nutrition & Metabolism  (2015) 12:11 Page 3 of 11hemodynamic recordings, blood samples were with-
drawn from the heart and the animals were sacrificed
with an overdose of anesthesia (pentobarbitone sodium
100 mg/kg, i.v.). Their hearts were excised and processed
for histopathological, ultrastructural, immunohistochem-
ical, biochemical and molecular studies. The serum was
separated via centrifugation (Heraeus Biofuge, Germany)
at 3000g for 5 min.
Biochemical studies
Ice-chilled phosphate buffer (0.1 M, pH 7.4) was used to
prepare 10% heart homogenate and from that an aliquot
was used for the estimation of Malondialdehyde (MDA)
[13] and reduced Glutathione (GSH) levels [14]. In
addition, supernatant obtained at 3000g for 20 min at 4°C
was used to measure Lactate Dehydrogenase (LDH) and
Nitrite levels (NO) [15], and Superoxide Dismutase (SOD)
[16], Catalase (CAT) [17] and Glutathione Peroxidase
(GSHPx) [18] activities. Furthermore, Creatine Kinase-MB
(CK-MB) and Tumor Necrosis Factor-alpha (TNF-α)
levels were measured spectrophotometrically in serum.
Terminal deoxynucleotidyl transferase dutp nick End
labeling (TUNEL) assay
In situ cell death detection kit, POD (Roche, Germany)
was used to detect TUNEL positive cells following the
manufacturer’s instructions.
Histological and ultrastructural evaluation
Light and electron microscopic analysis of myocardial
tissue was performed according to the method described
in our previous study [19]. The pathologist performing
histopathological and ultrastructural examination was
blinded to the treatment protocol.
Western blot analysis
According to the method described in our previous
study [20], SDS-PAGE was used to separate heart tissues
protein samples (40 μg), which were then transferred to
nitrocellulose membrane (MDI, Ambala, India) and
blocked for 2 h with 5% bovine serum albumin or non-
fat dried milk. It was then incubated for 12 h at 4°C with
primary antibody. The primary antibodies were detected
with HRP-conjugated anti-rabbit/anti-mouse secondary
antibody. The antibody-antigen complexes were visual-
ized using enhanced chemiluminescence kit (Thermo
scientific) under FluorChem M Protein imaging System
(Bucher Biotec AG, Basel, Switzerland) and were quanti-
fied by Bio-Rad Quantity One 4.4.0 software (BIO-RAD,
Hercules, CA, USA).
Immunohistochemistry (IHC) analysis
VECTOR ABC KIT, CA, USA was used to perform IHC
according to the method described in our previous study[20]. Briefly, slides were deparaffinized and hydrated
through a series of xylene and graded alcohol. For anti-
gen retrieval, slides were kept in pre-warmed citrate buf-
fer (pH 6.0), washed 3 times for 5 minutes each in Tris
Buffer Saline (TBS) and blocked for 45 minutes in ABC
kit serum solution. After blocking, slides were then incu-
bated overnight with primary antibody (PPAR-γ and
TGF-β, 1:500 dilution) at 4°C. Moreover, slides were
rinsed 3 times in TBS for 5 min and incubated in 3%
H2O2 for 20 minutes to block the endogenous peroxid-
ase activity. Slides were then washed 2 times with TBS
and incubated for 45 minutes with secondary antibody
(1:200 dilution) at room temperature. Slides were then
again rinsed 3 times for 5 minutes with TBS and devel-
oped with 3,3′-diaminobenzidine. Slides were counter-
stained with haemotoxylin, mounted with DPX and
visualized under microscope.
Statistical analysis
The data were expressed as mean ± S.D. One way
ANOVA followed by post hoc Bonferroni test was done
using SPSS software 11.5. The value of P < 0.05 was con-
sidered as statistically significant.
Results
Effect of chrysin on hemodynamic and ventricular
functions
To investigate the ability of chrysin to alleviate cardiac
functions we evaluated its effect on hemodynamic and
ventricular assessments. Isoproterenol administration re-
sulted in significant (P < 0.001) hemodynamic impairment
in rats as observed through significantly reduced SAP,
DAP and MAP as compared to sham group (Figure 1a-c).
Similarly, significant (P < 0.001) ventricular dysfunction
was also observed as exhibited through decreased con-
tractility (+LVdP/dtmax), relaxation (−LVdP/dtmax)
and increased LVEDP (Figure 1d-f ). Interestingly, chry-
sin (15–60 mg/kg) dose dependently abolished the detri-
mental effect of isoproterenol and improved hemodynamic
and ventricular dysfunction as observed by significant
(P < 0.01) improvement in arterial pressures, ±LVdP/
dtmax and LVEDP, though the level of significance
(P < 0.001) was found to be greater with the highest
dose (60 mg/kg) as compared to other two doses
(Figure 1a-f). No significant change in HR was observed
in any of the groups (Figure 1g).
Effect of chrysin on various biochemical parameters
To further analyze the cardioprotective effect of chrysin,
we assayed various oxidant-antioxidant proteins (GSH
level and GSHPx, SOD and CAT activities), cardiac in-
jury markers (CK-MB and LDH levels), oxidative DNA
damage marker (8-OHdG level), MDA, NO and TNF-α
levels. Myocardial injury induced by isoproterenol led to
Figure 1 Effect of chrysin on hemodynamic parameters following isoproterenol-induced myocardial injury. (a) SAP: Systolic arterial
pressure; (b) DAP: Diastolic arterial Pressure; (c) MAP: Mean arterial pressure; (d) + LVdP/dtmax: Maximal positive rate of left ventricular pressure;
(e) -LVdP/dtmax: Maximal negative rate of left ventricular pressure; (f) LVEDP: Left ventricular end diastolic pressure and (g) HR: Heart rate. All
values are expressed as mean ± S.D (n = 10/group).*P < 0.001 vs. sham and §P < 0.05, αP < 0.01, †P < 0.001 vs. ISO.
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CAT activities and GSH, LDH and NO levels with con-
comitant increase in TNF-α, 8-OHdG, MDA and CK-MB
levels, thus further strengthening the evidence for oxida-
tive and inflammatory damage due to isoproterenol. Rats
fed with chrysin (15–60 mg/kg) dose dependently normal-
ized the above mentioned biochemical parameters though
the effect was most pronounced (P < 0.01) at 60 mg/kg as
compared to other two doses (Figures 2a-f and 3a-d).
Effect of chrysin on various protein expression changes
To better understand the molecular role of chrysin in
isoproterenol-insulted myocardium, we studied protein
expression changes. Western blot analysis revealed that
chrysin (15–60 mg/kg) dose dependently and significantly
(P < 0.001) increased PPAR-γ and suppressed TGF-β
protein expression as compared to isoproterenol group
(Figure 4a and b).Besides, to delineate the role of inflammation in our
model, we assessed several inflammatory markers in
heart. Western analysis revealed that chrysin mediated
inhibition of inflammatory signaling in isoproterenol-
induced myocardial injury is significantly (P < 0.001)
linked to decreased NF-κBp65 and IKK-β protein ex-
pression in heart (Figure 4c and d).
To further strengthen our western blotting findings,
we performed immunohistochemistry analysis to check
the distribution and localization of PPAR-γ and TGF-β
within the myocardial cells. In consonance with western
blotting results, we also found that chrysin significantly
augmented PPAR-γ expression and mitigated TGF-β ex-
pression in recovered myocardium as compared to the
failing myocardium (Figures 5a3-f3 and a5-f5).
Furthermore, to establish the potential role of chrysin
on cell differentiation and survival, we studied protein
expressions of MMP-2 and MAPKs pathway involving
Figure 2 Effect of chrysin on anti-oxidant parameters and NO level following isoproterenol-induced myocardial injury. (a) GSH: Reduced
glutathione; (b) MDA: Malondialdehyde; (c) SOD: Superoxide dismutase; (d) CAT: Catalase; (e) GSHPx: Glutathione peroxidase and (f) NO: Nitric
oxide. All values are expressed as mean ± S.D (n = 6/group).*P < 0.001 vs. sham and §P < 0.05, αP < 0.01, †P < 0.001 vs. ISO.
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Intriguingly, we found that rats fed with chrysin augmented
P-ERK½ to ERK½ protein expression ratio and attenuated
P-p38 to p38 and P-JNK to JNK protein expression ratio
and MMP-2 protein expression at 30 and 60 mg/kg but
the effect was more significant (P < 0.001) at the highest
dose following isoproterenol-induced myocardial injury
(Figures 6a-d).
Effect of chrysin on apoptosis
Next, we focused our interest on measuring the role of
chrysin on apoptotic cell turnover in isoproterenol-
challenged myocardium. To measure this, we performed
TUNEL positivity assay as it allows immunohistochemi-
cal detection and quantification of apoptosis at single
cell level based on specific labeling of nucleus DNA
strand breaks. Chrysin dose dependently (P < 0.001) mit-
igated TUNEL positivity in isoproterenol treated rats,
thereby validating a strong role of its anti-apoptotic
property (Figures 3e and 5a4-f4).Effect of chrysin on histopathological and ultrastructural
assessment
Figure 5a1 illustrates light micrograph features of sham
group showing normal architecture of myocardium. In
contrast, isoproterenol group showed extensive cardio-
myocyte membrane damage with inflammatory cell infil-
tration, myonecrosis and marked edema (Figure 5b1 and
Table 1). Chrysin (15–60 mg/kg) resulted in significant
structural improvement as evidenced by decreased myo-
necrosis, edema and inflammatory cell infiltration in myo-
cardium, the effect being most pronounced at 60 mg/kg
(Figures 5c1-e1) and Table 1).
Figure 5a2 illustrates ultrastructural sections of sham
group showing normal mitochondrial structure and
myofibrils. Isoproterenol administration resulted in sig-
nificant myofibrillar derangement, irregular mitochon-
dria and chromatin condensation (Figure 5b2). Chrysin
dose dependently improved ultrastructural components
of the cardiomyocyte as the improvement was most
pronounced in 60 mg/kg group (Figures 5c2-e2). The
Figure 3 Effect of chrysin on cardiac injury markers and 8-OHdG and TNF-α levels and TUNEL positivity following isoproterenol-
induced myocardial injury. (a) LDH: Lactate dehydrogenase; (b) CK-MB: Creatine Kinase-MB; (c) 8-OHdG: 8-hydroxy-2-deoxyguanosine; (d) TNF-
α: Tumor necrosis factor-α and (e) Quantification of cardiomyocyte TUNEL positive nuclei. All values are expressed as mean ± S.D (n = 6/group).
*P < 0.001 vs. sham and §P < 0.05, αP < 0.01, †P < 0.001 vs. ISO.
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group (Figures 5f1 and f2) were similar to those found
in sham group (Figures 5a1 and a2).
Discussion
Pharmacological strategies targeted at activating PPAR-γ
and suppressing TGF-β expression in pre-clinical studies
have shown promising results in alleviating myocardial
injury [5,6,10,11]. The results of the present study pro-
vide convincing evidence that oral administration of a
novel compound, chrysin, exhibited a significant cardio-
protective effect in isoproterenol-induced animal model
of myocardial injury via PPAR-γ activation and TGF-β
inhibition. The underlying mechanism behind this novel
effect was primarily mediated through modulation of
MAPKs and subsidence of apoptotic and inflammatory
signaling pathway as observed via downregulation of
TUNEL positivity and TNF-α/NF-κBp65/IKK-β expres-
sion respectively.Catecholamines are known to regulate myocardial
function. At a low dose, they exert inotropic effect and
are beneficial, whereas at a high dose they produce
deleterious effect on cardiac metabolism. Likewise, iso-
proterenol, a synthetic catecholamine and β-adrenergic
agonist has been known to induce myocardial injury in
rats. The myocardial damage produced by isoproterenol
is irreversible in nature and occurs via free radical gener-
ation due to auto-oxidation and positive inotropic and
chronotropic effect. Since hemodynamic, ventricular,
biochemical, morphological, and histopathological changes
following high dose isoproterenol administration in rats re-
semble closely to those occurring in patients with myocar-
dial infarction, the isoproterenol-induced MI serves as a
well-standardized model to study the beneficial effects and
mechanism of many drugs [19,21-23]. As anticipated, in
the present study, isoproterenol administered rats showed
hemodynamic and ventricular dysfunction as evident by de-
creased contractility and relaxability and elevated preload
Figure 4 Effect of chrysin on PPAR-γ, TGF-β and inflammatory protein expressions following isoproterenol-induced myocardial injury.
(a) PPAR-γ; (b) TGF-β; (c) NF-κBp65 and (d) IKK-β. All values for protein expressions are expressed as mean ± S.D (n = 3/group). #P < 0.01,
*P < 0.001 vs. sham and §P < 0.05, αP < 0.01, †P < 0.001 vs. ISO.
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tional abnormalities in heart were accompanied as well as
substantiated with amplified necrosis, inflammatory cell
infiltration and edema as observed on light and electron
microscopical studies. Conversely, chrysin at the highest
two doses (30 and 60 mg/kg) markedly improved the car-
diac dysfunction and preserved the morphological archi-
tecture of the heart. The governing factors involved in
improving hemodynamic status could be due to direct
vasodilatory effect of chrysin via stimulating endothelial
formation of NO and/or due to Na+-K+ pump activation
perhaps through endothelium-derived hyperpolarizing
factor [24-26]. Chrysin activates PPAR-γ receptors and it
is well known that activation of PPAR-γ has a positive
effect on cardiac metabolism and inhibition of cytosolic
calcium overload [12,27]. Furthermore, modulation of
downstream signaling pathways of TGF-β by chrysin viz.
ERK½ activation and p-38/JNK/MMP-2 inhibition cannot
be ruled out as a possible mechanism as these MAPKsplays a significant role in cardiomyocyte survival and de-
mise [28,29]. Thus, the beneficial effect of chrysin on car-
diac function is largely attributed through collective effect
of activation of PPAR-γ and modulation of MAPKs.
Interplay between PPAR-γ, TGF-β and oxidative stress
plays a crucial role in regulating myocardial injury. In
the present study, isoproterenol-induced activation of
oxidative stress has shown to modulate cardiac injury
markers (CK-MB and LDH levels), attenuate PPAR-γ ex-
pression, reduce NO and GSH levels and GSHPx, CAT
and SOD activities which were accompanied with ampli-
fied oxidative DNA damage marker (8-OHdG level),
TGF-β expression and malondialdehyde level. Gener-
ation of free radicals by isoproterenol occurs via its
quinine metabolites that react with oxygen to produce
ROS, hydrogen peroxides and superoxide anions, which
eventually consume and deplete the stores of endogenous
antioxidants like GSH, GSHPx, SOD and catalase in myo-
cardium. Also, malondialdehyde, a biomarker of oxidative
Figure 5 Effect of chrysin on a1-f1: Light microscopic changes (10X, Scale bar 100 μm), a2-f2: Electron microscopic changes (4000X,
Scale bar 1 μm, N: nucleus; MC: mitochondria; F: myofibrils), a3-f3: PPAR-γ immunohistochemistry (10X, Scale bar 50 μm), a4-f4: TUNEL
positivity (20X, Scale bar 100 μm) and a5-f5: TGF-β immunohistochemistry (10X, Scale bar 50 μm) in different experimental groups.
Sham group (a1-a5); ISO (b1-b5); Chr15, 30, 60 + ISO mg/kg respectively (c1-c5, d1-d5 and e1-e5); and Chr60ps (f1-f5).
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urated fatty acids, is also augmented by isoproterenol.
ROS so produced through these processes are toxic by-
products of aerobic metabolism and are known to react
extensively with cellular membrane and macromolecules
thereby activating so called “Oxidative Machinery” in
myocardium. Once activated, this machinery imbalances
cardiac metabolism and hemostasis resulting in oxidative
stress-induced myocyte demise [21-23,30]. Intriguingly,
these biochemical and molecular changes were signifi-
cantly normalized by chrysin in a dose dependent fashion
as we observed improvement in redox status and NO level
in the recovered myocardium. This was likely due to inter-
action of chrysin with the circulating free radicals pro-
duced during homeostatic processes and scavenging of
superoxide, nitrosative, hydroxyl and lipid peroxyl radicals
into non-harmful compounds as observed through ampli-
fication of intracellular GSH level and GSHPx, CAT and
SOD activities. This correction may also be attributed tothe direct antioxidant activity and scavenging properties
of the hydroxyl groups in the 5th and 7th position of chry-
sin [31]. Additionally, PPAR-γ activation-mediated inhib-
ition of oxidative stress by chrysin could also be one of the
interesting mechanisms as it has shown to positively regu-
late myocardial energy metabolism and homeostasis via
inhibiting ROS. Furthermore, direct PPAR-γ/ERK½ activa-
tion and TGF-β/p-38/JNK/MMP-2 inhibition has also
shown to prevent the activation of NADPH oxidase and
ROS production which could also be advocated as a po-
tential protective mechanism of chrysin in limiting oxida-
tive stress mediated myocardial injury. Moreover, this is in
accordance with various other findings where chrysin has
shown potent anti-oxidant effect in abrogating the cellular
injury [31-35].
To further validate the antioxidant potential of chrysin,
we assessed the effect of chrysin on 8-hydroxy-2-deoxy
guanosine (8-OHdG), a product of oxidatively modified
DNA base guanine and an established marker of degree of
Figure 6 Effect of chrysin on MAPKs protein expressions following isoproterenol-induced myocardial injury. (a) ERK½ and P-ERK½;
(b) JNK and P-JNK; (c) p38 and P-p38 and (d) MMP-2. All values for protein expressions are expressed as mean ± S.D (n = 3/group). #P < 0.01,
*P < 0.001 vs. sham and §P < 0.05, †P < 0.001 vs. ISO.
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found to be directly correlated in patients with heart fail-
ure and is one of the most common adducts formed by
oxidative DNA damage by reactive oxygen species. In
accordance with the previous studies [36-38], we alsoTable 1 Effect of chrysin on histopathological grading
Treatment Groups Myonecrosis Inflammatory Edema
Sham - - -
ISO +++ +++ +++
Chr15 + ISO +++ ++ ++
Chr30 + ISO ++ + +
Chr60 + ISO + + +
Chr60ps - - -
Score (−): Absence of any myonecrosis, edema and inflammation; Score (+):
Focal areas of myonecrosis, edema and inflammation; Score (++): Patchy areas
of myonecrosis, edema and inflammation; Score (+++): Confluent areas of
myonecrosis, edema and inflammation; Score (++++): Massive areas of
myonecrosis, edema and inflammation (n = 6/group).observed augmented level of 8-OHdG following myocar-
dial damage. Chrysin in a dose dependent fashion signifi-
cantly abrogated the increased 8-OHdG level which could
be due to decreased ROS production via its antioxidant
properties or upregulation of antioxidant enzymes. Simi-
larly, several investigators have demonstrated the ability of
chrysin to protect cellular damage and subsequent cell
death [31-35].
Apart from improving the myocardial function and
redox status of the myocardium, chrysin also showed
significant contribution towards inhibiting inflammatory
and apoptotic signaling pathways via antagonism of
TNF-α/NF-κBp65/IKK-β and TUNEL positivity. This sa-
lubrious effect may be in part due to PPAR-γ activation
by chrysin, as it is regarded as the master switch in
controlling inflammation and its stimulation has been
directly associated with inhibition of recruitment of in-
flammatory cytokines and suppression of NF-κBp65 and
IKK-β protein expression [39,40]. Moreover, other plausible
Rani et al. Nutrition & Metabolism  (2015) 12:11 Page 10 of 11mechanism for its anti-inflammatory and anti-apoptotic
response could be due to stimulation of ERK½ and/or in-
hibition of TGF-β/p-38/JNK/MMP-2 pathway as MAPKs
has been regarded as one of the key regulator for cardio-
myocyte apoptotic and inflammatory signaling pathway.
In line with our findings, other studies have also estab-
lished the role of chrysin as an anti-inflammatory and
anti-apoptotic molecule [26-28,35,39,40].
Conclusion
In view of the aforementioned findings, the relationship
between chrysin-PPAR-γ-TGF-β seems to be correlative
and demands subsequent experimental and clinical stud-
ies to fully realize its ability as a potent cardioprotective
agent. Moreover, chrysin holds the potential as a novel
phytopharmaceutical in ameliorating myocardial injury
through inhibiting inflammatory and apoptotic signaling
pathway and it could open many interesting avenues
aimed at activating PPAR-γ or inhibiting TGF-β targeted
therapeutics.
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